Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Mor, US
Dafna Mor, East Aurora, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100210170 | Posable Toy and Method of Forming - A toy with repositionable portions is disclosed. The toy may be stylized as a toy figure that may include a leg section and a torso section. The leg section includes legs pivotally coupled to a pelvic section. The pelvic section may also include an upward-extending connection post. The torso section, furthermore, may include a body cylinder that connects to the connection post. The body cylinder includes a series of resilient tabs that slidingly engage the post, securing the sections together while permitting the rotation of the torso section about the post. With this configuration, the toy figure possesses multiple degrees of motion, being adapted to move in bending and twisting motions. | 08-19-2010 |
David Mor, Merrimack, NH US
| Patent application number | Description | Published |
|---|---|---|
| 20080229236 | Non-linear navigation in discussion forums - Systems, methods, and other embodiments associated with providing non-linear navigation in a discussion forum are described. One method embodiment includes maintaining a location data that identifies a thread or message to which a user has navigated. The method also includes manipulating a navigation control in a graphical user interface based on actions taken by the user and/or other users of the system. The navigation control facilitates a user moving to points not traditionally reachable in a single vertical navigation step in a discussion forum interface. | 09-18-2008 |
| 20100161645 | Change management - Systems, methods, and other embodiments associated with artifact type neutral change management are described. One example method includes maintaining an access table for each artifact in a collaborative software environment that records a most recent access of an artifact on a per user basis. An artifact type registration table is also maintained that maps each artifact type to the access table that records access information for artifacts of the given type and to a data store that stores artifacts of that type. For a given user, artifact pair, queries on the type registration table, access table, and data store are generated to return the last modification time for the artifact and the user's last access time for the artifact. This information is used to determine a change status of the artifact for the given user. This common framework can be used for artifacts of any type that are registered in the type registration table. | 06-24-2010 |
| 20100217804 | Collaborative draft forum-messages - Systems, methods, and other embodiments associated with collaborative draft forum-messages are described. One example method includes receiving draft forum-message data from a drafter. The draft forum-message data may identify a set of entities to whom the drafter seeks to grant edit privileges. The example method may also include providing a portion of the draft forum-message data to one of the identified entities and allowing them to view and/or modify the draft forum-message data. | 08-26-2010 |
Ebrahim Mor, Laguna Niguel, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100330861 | HYDROPHOBIC ADDITIVE FOR USE WITH FABRIC, FIBER, AND FILM - The present invention relates to a hydrophobic additive for use with fabric, fiber, and film. One aspect of the present invention comprises a master batch composition for use in preparing a non-woven fabric in order to increase the hydrophobicity of the non-woven fabric. In one embodiment, the master batch composition includes a polymer and a lipid ester. The lipid ester comprises from 10 wt. % to 40 wt. % of the master batch. The fabric, when including the master batch composition, has a contact angle ranging from 100° to 125° when measured according to test method ASTM D2578. | 12-30-2010 |
Gil Mor, Cheshire, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100130598 | METHODS FOR INDUCING PROGRAMMED CELL DEATH - The present invention relates to methods for inducing or promoting caspase-independent apoptosis in a cell, the method comprising exposing to the cell an effective amount of a compound of formula I as described herein. The invention also relates to methods for treating or preventing diseases and disorders by administering to subjects in need thereof an effective amount of a compound of formula I, wherein the compound induces or promotes caspase-independent apoptosis in at least one cell of the subject. | 05-27-2010 |
Gil Mor, New Haven, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100173983 | METHOD FOR INDUCING AUTOPHAGY - The present invention relates to methods for inducing or promoting autophagy in a cell, the method comprising exposing to the cell an effective amount of a compound of formula I as described herein. The invention also relates to methods for treating or preventing diseases and disorders by administering to subjects in need thereof an effective amount of a compound of formula I, wherein the compound induces or promotes autophagy in at least one cell of the subject. | 07-08-2010 |
Gil G. Mor, Cheshire, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090220427 | Drug Resistance and Methods of Reversing - Described herein is a cellular marker, MyD88, useful for assessing an individual's (patient's) sensitivity (or resistance) to chemotherapy, particularly sensitivity (or resistance) to chemotherapeutic drugs, such as plant alkaloids (e.g., a taxane, such as paclitaxel or docetaxel). As described herein, Applicants provide a method by which it is possible to determine whether an individual (cancer cells in an individual) is sensitive to chemotherapy with plant alkaloids (e.g., a taxane, such as paclitaxel or docetaxel). Early identification of chemoresistance in patients with cancer is of utmost importance, particularly since it makes it possible to provide the most appropriate therapy. | 09-03-2009 |
| 20100311047 | Identification Of Cancer Protein Biomarkers Using Proteomic Techniques - The claimed invention describes methods to diagnose or aid in the diagnosis of cancer. The claimed methods are based on the identification of biomarkers which are particularly well suited to discriminate between cancer subjects and healthy subjects. These biomarkers were identified using a unique and novel screening method described herein. The biomarkers identified herein can also be used in the prognosis and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer. | 12-09-2010 |
Guillermo Mor, New Haven, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100173341 | APOPTOSIS-BASED EVALUATION OF CHEMOSENSITIVITY IN CANCER PATIENTS - Induction of apoptosis in target cells is a key mechanism by which chemotherapy induces cell killing. An in vitro system has been established for determining carboplatin and paclitaxel (Taxol) chemosensitivity of epithelial ovarian cancer cells, where measurements of caspase-3 activation are surrogate markers for activation of chemotherapy-induced programmed cell death. To validate the assay as a predictor of clinical chemotherapy-induced programmed cell death. To validate the assay as a predictor of clinical chemosensitivity in vitro apoptotic response were compared to the clinical response of the patients from whom the tumor cells were isolated. Caspase-3 activation in response to in vitro chemotherapy to both drugs was shown to have an 83% positive predictive value and a 71% negative predictive value. Markers of apoptosis such as caspase-3 activation can be quantitated and utilized to predict the clinical response to chemotherapy. | 07-08-2010 |
Tsafrir S. Mor, Tempe, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20090117145 | Composition and Method For Enhancing Immune Response - A composition and method for enhancing immune response in a living organism is disclosed. In particular, the present disclosure provides an adjuvant peptide for use in raising an immune response to an antigen. The adjuvant peptide is selected from a group of peptides with an HIV-related sequence. Additionally, the adjuvant peptide can comprise a fusion-protein that acts as a mucosal adjuvant. The adjuvant peptide can be transformed into one or more living cells, such that the mucosal adjuvant can be produced in living cells and then administered by systemic, mucosal or epidermal delivery. | 05-07-2009 |
| 20090274679 | PRODUCTION AND USE OF HUMAN BUTYRYLCHOLINESTERASE - The present invention concerns the production of human butyrylcholinesterase (BuChE) in transgenic plants and use of the derived BuChE as effective countermeasures against toxic agents such as pesticides, toxins, certain drugs and non-conventional warfare agents, as well as treatments for diseases and conditions associated with depressed cholinesterase levels. | 11-05-2009 |